University of Illinois - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
54
About the Report
About the Report
Summary
University of Illinois (UOL) is a university that offers undergraduate, graduate, and professional programs. The university offers online and continuing education programs such as undergraduate and graduate online degrees. It provides research activities in the areas of alternative, complementary and traditional medicine; biotechnology and biodefense; cancer biology and therapeutics; drug discovery, development and delivery; infectious diseases; natural products; neuroscience; patient safety; and pharmacoeconomics. The university offers courses through the College of Agricultural, Consumer and Environmental Sciences; College of Applied Health Sciences; Institute of Aviation; College of Business; College of Education; College of Engineering; and College of Fine and Applied Arts, among others. UOL is headquartered in Urbana, Illinois, the US.
University of Illinois-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
University of Illinois, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Illinois, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Illinois, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Illinois, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Illinois, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Illinois, Medical Devices Deals, 2012 to YTD 2018 10
University of Illinois, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
University of Illinois, Pharmaceuticals & Healthcare, Deal Details 12
Licensing Agreements 12
Revivo Therapeutics Receives Technology Rights from University of Illinois and Queens University 12
Ocugen Enters into Licensing Agreement with University of Illinois at Chicago 13
Revolution Medicines Enters into Licensing Agreement with University of Illinois 14
Actuate Therapeutics Enters into Licensing Agreement with University of Illinois at Chicago and Northwestern University 15
Cortex Pharma Enters into Licensing Agreement with University of Illinois 16
zuChem Enters Into Licensing Agreement With University Of Illinois At Urbana-Champaign 18
University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds 19
Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 20
Equity Offering 21
ResQ Pharma Spins Out from University of Illinois 21
University of Illinois-Key Competitors 22
University of Illinois-Key Employees 23
University of Illinois-Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Government and Public Interest 26
Sep 20, 2018: Smart pills dumb down medical care, experts warn 26
Sep 04, 2018: UIC to lead study of negative pressure wound therapy in obese and diabetic patients 28
Aug 16, 2018: New CRISPR technique skips over portions of genes that can cause disease 29
Aug 01, 2018: Nowhere to hide: Molecular probe illuminates elusive cancer stem cells in live mice 31
Jul 30, 2018: Magnetic nanoparticles deliver chemotherapy to difficult-to-reach spinal tumors 32
Jun 21, 2018: DNA enzyme shuffles cell membranes a thousand times faster than its natural counterpart 33
Jun 20, 2018: New tissue-imaging technology could enable real-time diagnostics, map cancer progression 34
Jun 20, 2018: Researchers discover a starring role for chaperone protein Hfq in gene regulation 36
May 21, 2018: New technique can track drug and gene delivery to cells 38
May 07, 2018: New CRISPR technology 'knocks out' yeast genes with single-point precision 39
Mar 12, 2018: Study yields more than a million new cyclic compounds, some with pharmaceutical potential 40
Feb 26, 2018: NIH awards USD 4.6 million for chronic pain research 41
Dec 19, 2017: Unsuspected flexibility offers new pathway to cancer drug development 42
Dec 07, 2017: Quick evaluation can predict whether drugs, talk therapy work better for anxiety patients 44
Nov 27, 2017: Stem cells in intestinal lining may shed light on behavior of cancer cells 46
Nov 06, 2017: Stem cells from muscle could address diabetes-related circulation problems 48
Jul 17, 2017: Epilepsy biomarkers pave way for noninvasive diagnosis, better treatments 50
Feb 14, 2017: Tumor-targeting system uses cancer's own mechanisms to betray its location 51
Product News 52
Nov 27, 2017: Drug-delivering nanoparticles seek and destroy elusive cancer stem cells 52
Feb 12, 2018: Tiny drug-delivering capsules could sustain transplanted insulin-producing cells for diabetics 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54
List of Figure
List of Figures
University of Illinois, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Illinois, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Illinois, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Illinois, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Illinois, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Illinois, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
University of Illinois, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Illinois, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Illinois, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
University of Illinois, Pharmaceuticals & Healthcare, Key Facts 2
University of Illinois, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Illinois, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Illinois, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Illinois, Deals By Therapy Area, 2012 to YTD 2018 9
University of Illinois, Medical Devices Deals, 2012 to YTD 2018 10
University of Illinois, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Revivo Therapeutics Receives Technology Rights from University of Illinois and Queens University 12
Ocugen Enters into Licensing Agreement with University of Illinois at Chicago 13
Revolution Medicines Enters into Licensing Agreement with University of Illinois 14
Actuate Therapeutics Enters into Licensing Agreement with University of Illinois at Chicago and Northwestern University 15
Cortex Pharma Enters into Licensing Agreement with University of Illinois 16
zuChem Enters Into Licensing Agreement With University Of Illinois At Urbana-Champaign 18
University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds 19
Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 20
ResQ Pharma Spins Out from University of Illinois 21
University of Illinois, Key Competitors 22
University of Illinois, Key Employees 23
University of Illinois, Subsidiaries 24
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.